Figure 6.
Changes of A620/520 of the scFv-cys stabilized gold NPs solution after addition of after addition of 85 nM rabbit IgG (i), 100 nM BSA (ii), 5k diluted human serum (iii), 200 diluted anti-mouse IgG (iv), and the gold nanoparticles treated with scFv-SR after addition of 85 nM rabbit IgG (v). (n = 3)